EP2900240
CRYSTALLINE FORM OF A REVERSE TRANSCRIPTASE INHIBITOR
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
20.9.2013EP published:
8.1.2020EP application number:
13840379.5
EPO information:
European Patent Register
Max expiry date:
19.9.2033
Title:
CRYSTALLINE FORM OF A REVERSE TRANSCRIPTASE INHIBITOR
Timeline
Today
20.9.2013EP application
8.1.2020EP Publication
Owner
Name:
Merck Sharp & Dohme Corp.Address:
126 East Lincoln Avenue, Rahway, NJ 07065-0907, US
Inventor
Name:
MAGUIRE, Courtney, K.Address:
Rahway, New Jersey 07065-0907, US
Priority
Number:
201261705780 PDate:
26.9.2012Country:
US
Classification
Categories:
C07D 401/06, A61K 31/4439